Article (Published version) (528 Kb) - 
Limited access to UNIGE
Highlights
Scientific Article - Review
unige:150570 
 |
Glycan-directed CAR-T cells |
|
| Authors | ||
| Published in | Glycobiology. 2018, vol. 28, no. 9, p. 656-669 | |
| Abstract | Cancer immunotherapy is rapidly advancing in the treatment of a variety of hematopoietic cancers, including pediatric acute lymphoblastic leukemia and diffuse large B cell lymphoma, with chimeric antigen receptor (CAR)-T cells. CARs are genetically encoded artificial T cell receptors that combine the antigen specificity of an antibody with the machinery of T cell activation. However, implementation of CAR technology in the treatment of solid tumors has been progressing much slower. Solid tumors are characterized by a number of challenges that need to be overcome, including cellular heterogeneity, immunosuppressive tumor microenvironment (TME), and, in particular, few known cancer-specific targets. Post-translational modifications that differentially occur in malignant cells generate valid cell surface, cancer-specific targets for CAR-T cells. We previously demonstrated that CAR-T cells targeting an aberrant O-glycosylation of MUC1, a common cancer marker associated with changes in cell adhesion, tumor growth and poor prognosis, could control malignant growth in mouse models. Here, we discuss the field of glycan-directed CAR-T cells and review the different classes of antibodies specific for glycan-targeting, including the generation of high affinity O-glycopeptide antibodies. Finally, we discuss historic and recently investigated glycan targets for CAR-T cells and provide our perspective on how targeting the tumor glycoproteome and/or glycome will improve CAR-T immunotherapy. | |
| Keywords | Animals — Humans — Immunotherapy — Neoplasms/immunology/therapy — Polysaccharides/immunology — Receptors, Antigen, T-Cell/immunology | |
| Identifiers | PMID: 29370379 | |
| Full text | ||
| Citation (ISO format) | STEENTOFT, Catharina et al. Glycan-directed CAR-T cells. In: Glycobiology, 2018, vol. 28, n° 9, p. 656-669. doi: 10.1093/glycob/cwy008 https://archive-ouverte.unige.ch/unige:150570 |
72 hits 
0 download 
Contact an author
Update